MwanzoCIPLA • NSE
add
Cipla Ltd
Bei iliyotangulia
₹ 1,502.80
Bei za siku
₹ 1,480.00 - ₹ 1,510.50
Bei za mwaka
₹ 1,335.00 - ₹ 1,702.05
Thamani ya kampuni katika soko
1.22T INR
Wastani wa hisa zilizouzwa
1.85M
Uwiano wa bei na mapato
23.11
Mgao wa faida
0.86%
Ubadilishanaji wa msingi
NSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 65.98B | 6.89% |
Matumizi ya uendeshaji wa biashara | 31.80B | 15.17% |
Mapato halisi | 12.22B | 30.12% |
Kiwango cha faida halisi | 18.52 | 21.76% |
Mapato kwa kila hisa | 15.12 | 30.12% |
EBITDA | 15.06B | 11.75% |
Asilimia ya kodi ya mapato | 18.70% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 80.93B | 3.81% |
Jumla ya mali | 373.87B | 14.27% |
Jumla ya dhima | 60.98B | 3.08% |
Jumla ya hisa | 312.89B | — |
hisa zilizosalia | 807.62M | — |
Uwiano wa bei na thamani | 3.89 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 10.13% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 12.22B | 30.12% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1935
Makao Makuu
Tovuti
Wafanyakazi
27,764
